Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF.
about
PEGylation of Interferon-β-1aSafety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding.The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia.Investigational drugs for coagulation disorders.Recent developments in protein and peptide parenteral delivery approaches.Prolonged effect of a new O-glycoPEGylated FVIII (N8-GP) in a murine saphenous vein bleeding model.
P2860
Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancement of the efficacy of ...... ase of FVIII, FVIIa and G-CSF.
@en
Enhancement of the efficacy of ...... ase of FVIII, FVIIa and G-CSF.
@nl
type
label
Enhancement of the efficacy of ...... ase of FVIII, FVIIa and G-CSF.
@en
Enhancement of the efficacy of ...... ase of FVIII, FVIIa and G-CSF.
@nl
prefLabel
Enhancement of the efficacy of ...... ase of FVIII, FVIIa and G-CSF.
@en
Enhancement of the efficacy of ...... ase of FVIII, FVIIa and G-CSF.
@nl
P2093
P2860
P1476
Enhancement of the efficacy of ...... ase of FVIII, FVIIa and G-CSF.
@en
P2093
Inbal Dayan
Micah Robinson
Moshe Baru
Rivka Yatuv
P2860
P304
P356
10.1517/17425240903463846
P407
P577
2010-02-01T00:00:00Z